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Prognostic Significance of Ventricular Ectopic Activity in Survivors of
Acute Myocardial Infarction
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SIDNEY GOLDSTEIN, MD, FACC,§ CURT FURBERG, MD,II FOR THE BHAT STUDY GROUP
Twenty-four hour ambulatory electrocardiography was
performed on 3,290 survivors of acute myocardial in-
farction participating in the Beta-Blocker Heart Attack
Trial (BHAT). History of myocardial infarction before
the qualifying event, congestive heart failure and age
were independently associated with the frequency and
complexity of ventricular premature beats. Of the 1,640
patients randomized to placebo therapy, 163 died (76
suffered sudden death) during a 25 month average fol-
low-up period. Ventricular ectopic activity was an in-
dependent predictor of total mortality after taking into
consideration 16other prognostic factors describing past
history, risk factors, physical examination and labora-
tory investigations.
Seven categoric definitions of ventricular ectopic ac-
tivity predicted mortality, with similar odds ratios rang-
ing from 2.27 to 2.69. A reciprocal relation of the sen-
sitivity and specificity of each definition in predicting
mortality was observed. Three clinical criteria (ST
depression, cardiomegaly and prior infarction) allowed
stratification of patients into four subsets with respective
A relation between ventricular ectopic activity recorded 1
to 3 weeks after an acute myocardial infarction and future
mortality has been reported (1-36). Although this relation
may be explained by the association of ectopic activity
with other factors aggravating prognosis (for example, the
degree of left ventricular dysfunction), many studies
(15,16,19,24,25,29,30,32,33,35) suggest that ventricular
arrhythmia contributes to the risk independently of other
prognostic factors.
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mortality rates of 35.5% (three criteria present), 19.0%
(two criteria), 11.5% (one criterion) and 4.7% (none).
Presence of ventricular ectopic activity (2: 10 ventricular
premature beats/h or pairs, ventricular tachycardia or
multiform complexes) was associated with higher mor-
tality rates in all four risk strata. The relative risk was
higher (3.86) in the lowest risk stratum (mortality 2.4%
without and 9.1% with ventricular ectopic activity).
Thus, in survivors of acute myocardial infarction,
ventricular ectopic activity was more pronounced in pa-
tients with prior myocardial infarction and congestive
heart failure. It predicted mortality independently of
other factors. Although mortality ratios were similar for
all seven arrhythmia definitions, a reciprocal relation
between sensitivity and specificity of the definitions in
predicting mortality existed; ventricular ectopic activity
was associated with increased mortality in all risk strata,
but with a higher risk ratio in the numerically larger,
low risk subset.
(J Am Coli CardioI1987;JO:231-42)
Additional data on the prognostic value of ventricular
ectopic activity are desirable because the relative usefulness
of various definitions of ectopic activity has not been as-
sessed accurately, the contribution of ambulatory electro-
cardiography (ECG) in determining the risk of mortality in
different subsets of survivors of myocardial infarction is not
known and there are only a few studies with a large number
of patients studied by 24 hour ambulatory ECG. To answer
these questions, the Beta Blocker Heart Attack Trial (BHAT)
allowed the collection of data on a large number of patients
from a wide geographic distribution. This report pertains to
1,640 patients with a recent myocardial infarction who were
randomized into the BHAT placebo group and who had a
24 hour ambulatory ECG at baseline study.
The objectives of this report are I) to define the useful-
ness of various definitions of ventricular ectopic activity in
predicting the mortality rate among survivors of acute myo-
cardial infarction; 2) to describe a simple risk classification
system based on easily obtained clinical variables; and 3)
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to define the value of ambulatory ECG in determining risk
in patient subsets with a high or low risk for mortality. In
addition, the association of ventricular ectopic activity with
other clinical variables and its independent association with
future mortality are described .
Methods
Population and variables studied. The BHAT was a
multicenter randomized placebo-controlled double-blind
clinical trial with the primary objective of testing the effect
of long-term administration of propranolol on mortality in
patients who had survived ail acute myocardial infarction.
The design and baseline findings of the trial have been
reported elsewhere (37). The effect of propranolol on mor-
tality (that is, a significant decrease in total mortality, ath-
erosclerotic heart disease mortality and sudden cardiac death
[< I hour]) has also been reported (38) . The data presented
here pertain to 1,640 patients randomized to the placebo
group who had 24 hour ambulatory ECG 2 to 21 days after
admission to a coronary care unit. There was no correlation
between ventricular ectopic activity and the number of days
since the qualifying infarction (r = 0.059). Analyses of the
relation of the time interval between qualifying infarction
and ambulatory ECG with mortality were inconclusive be-
cause of the small number of deaths in some subsets. The
patients who did and did not have 24 hour ambulatory ECG
were not different in demographic and clinical character-
istics .
Patients with a definite acute myocardial infarction di-
agnosed by predetermined criteria (typical symptoms and
specified changes in cardiac enzymes and the ECG) were
enrolled by 31 clinical centers (134 hospitals). Patients with
a history of severe congestive heart failure, bronchial asthma
as an adult, marked bradycardia and life-threatening illness
other than coronary artery disease, those who had or were
likely to have aortocoronary bypass surgery and those who
were taking or were likely to take a beta-adrenergic blocking
agent were excluded. During approximately 2 years of en-
rollment, 3,837 patients were randomized (1,916 to pro-
pranolol therapy and 1921 to placebo therapy).
History , physical examination , 12 lead ECG, cardiac
enzymes, hematocrit, complete blood count and biochem-
ical determinations were obtained from all patients before
randomization. In addition, 24 hour ambulatory ECG was
performed in 3,290 patients (86% of all patients). In ap-
proximately 15% of the patients, ambulatory ECG could
not be done before randomization because of equipment and
personnel constraints and other administrative reasons. Two
channel, reel to reel ECG recordings were obtained using
portable tape recorders (Avionics model 445). They were
processed by a central laboratory (CardioData) using the
Worcester Polytechnic Institute Algorithm. This validated
computer-operator interactive system is able to differentiate
up to 25 different ECG rate and rhythm variables (39,40) .
A quality control program of blind analysis of previously
hand-counted tapes and blind reanalysis of 4% of the BHAT
tapes was used. Acceptable deviations in this quality control
procedure were a mean monthly error of < 7% in ventricular
ectopic activity counts compared with hand-counted tapes
and a maximal error in any given sample of less than 14%.
Follow-up. Follow-up visits were made I month and 6
weeks after randomization and every 3 months thereafter
for the duration of the study . Deaths during the mean 25
month follow-up period (range 12 to 40 months) were clas-
sified by a subcommittee of investigators unaware of the
treatment group assignment or the results of ambulatory
ECG. This group considered death certificates, attending
physician reports, hospital records , autopsy reports and in-
formation obtained from relatives and witnesses.
Data analysis. This report will first present the baseline
correlates of ventricular ectopic activity . Analysis of the
relation of ectopic activity to baseline variables was based
on the 3,290 patients who had ambulatory ECG before ran-
domization . Analyses evaluating the relation between ec-
topic activity and follow-up events are restricted to the 1,640
placebo-treated patients who underwent 24 hour baseline
ambulatory ECG monitoring (85% of all placebo-treated
patients) .
Among 40 baseline characteristics describing past med-
ical history (for example, angina, myocardial infarction),
risk factors, life style (for example, employment, exercise) ,
physical examination and laboratory determinations, II to
16 were used as independent covariates in multivariate lo-
gistic regression models describing the contribution of dif-
ferent definitions of ventricular ectopic activity in predicting
cause-specific mortality. These variables (listed in the Ap-
pendix) were selected from previous multivariate analyses
as the variables that best predicted cause-specific mortality
in the BHAT placebo-treated group of patients.
In addition. patients were stratified according to the pres-
ence or absence of three clinical characteristics (history of
prior myocardial infarction , cardiomegaly on chest X-ray
study defined by a cardiothoracic ratio > 0.50 and ST
depression on the rest ECG) . These characteristics were
chosen because of their strong association with mortality in
this and previous studies and because they are easily ob-
tained during routine care of patients . In this study, these
criteria had the third , fifth and sixth strongest association
with mortality (after age, ventricular ectopic activity and
congestive heart failure) .
Eleven definitions were used to describe ventricular ec-
topic activity . Four definitions are continuous [average num-
ber of ventricular premature beats (VPB)/h : In (VPB/h +
0.5); VPB pairs/h; episodes of ventricular tachycardia (2:3
consecutive beats)/h], while seven arc categoric [mean VPBsIh
>0; mean VPBs/h 2:10; presence of ventricular tachycardia
event or pairs; mean VPBs/h 2: 10 or ventricular tachycardia
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Table 1. 24 Hour Ambulatory Electrocardographic (Holter)
Characteristics of the BHAT Placebo Group at Baseline Study
*Geometric mean "" [exp(~ In(VPB + 0 .5 )/n ) - 0.5]. VPB = ven-
tricular premature beat: VT = ventricular tachycardia .
event or pairs; presence of multiform VPBs; VPBs/h 2: 10
and (ventricular tachycardia event or pair) and multiform;
VPB/h 2: 10 or (ventricular tachycardia event or pair) or
multiform] . Becauseof the problemof multiplecomparisons
and because many baseline characteristics and many end
Holter Characteristic
VPB/h (arithmetic mean)
VPB/h (median)
VPB/h (mode)
VPB/h (geometric mean)*
VPB pairs/h (mean)
VT events/h (mean)
Mean VPB/h > 0 (%)
Mean VPB/h ;;::1O (%)
VT event or VPB pairs
present (% )
VI'B ;;:: IO/h or (VT event
or pairs) (%)
Multiform VPB present (%)
VPB ;;:: IO/h and (VT event
or pairs) and multiform
complexes (o/c)
VPB ;;:: IO/h or (VT event
or pairs) or multiform
complexes (%)
Overall
(n = 1.640)
13.5
0 .298
0 .0
1.1
0.235
0 .020
84 .1
12.9
19.9
25.5
32.8
6 .8
40.6
Patients not
Receiving
Antiarrhythmic Drugs
at Entry (n = 1.349)
10.3
0.27 6
0 .0
0 .9
0.184
(U1I8
83.2
10.6
19.0
23.6
30.9
5.6
38.5
points are intercorrelated, probability (p) values are not pre-
sented in this report. Student's t test values and odds ratios
will be presented as guides to the magnitude of the asso-
ciations. Traditionally, t values > I. 96 are considered sig-
nificant.
Results
Prevalence and correlates of ventricular ectopic ac-
tivity at baseline (Tables 1 and 2). Table I shows the
characteristics of ventricular ectopic activity of the I ,640
patients with acute myocardial infarction recorded in the
BHAT placebo group. Eighty-four percent of the patients
had at least one ventricular premature beat/24 h, approxi-
mately 20% had repetitive forms, approximately 13% had
an average of 2: 10 ventricular premature beats/h and ap-
proximately 33% had multiform complexes. Similar values
pertained when the 291 patients who were receiving anti-
arrhythmic agents during ambulatory ECG were excluded
from the analysis. Also, analysis of the total coliart of 3,290
patients studied at baseline yielded similar results (arith-
metic mean 13 .3 VPB/h, median 0.29 VPBIh, mode 0 VPBIh,
patients with more than 0 VPB/h, 83.4%).
Multivariate linear regression analyses (Table 2) per-
formed for the 3,225 patients in the BHAT trial who had a
complete set of baselinedata using II independent variables
found to be univariately associated with ventriculararrhyth-
mia or hypothesized to be so related, showed significant
independent relations between ventricular ectopic activity
and the following three factors: history of a myocardial
Table 2. Multivariate Relation Between VentricularArrhythmias and II Baseline Variables: Multiple Linear Regression in
3,225 Patients
Dependent Variable = Dependent Variable = Dependent Variable =
In (VPB/h + 0 .5) Presence* of;;:: 10 VPB/h Presence" of "Complex..
VPB
Independent Baseline Adjusted Adjusted
Variables I Values Coefficient I Values Coefficient I Values Coefficient
Prior MI* 10 .57 0 .82 8.09 0.14 7.28 0 .18
Age (yr) 7.83 0.026 4.99 0 .004 7.06 0.008
Congestive heart failure* 3.76 0.28 :1.30 0 .06 2.98 0.07
Rose questionnaire angina 2.37 0 .20 2.09 0.04 0 .7H 0 .02
in past year*
Race (0 = black; 1 = - 2.03 -0.19 -1 .58 - 0.03 - 104 1 -0.04
white/other)
Systolic blood pressure 1.70 0.0040 1.44 0 .0008 2. 19 0 .002
(mm Hg)
Atrial fibrillation* 1.26 0.14 1.07 0 .27 1.93 0.07
ST depression* 0.95 0.06 - 0.39 -0.005 1.94 0 .04
Heart rate (beats/min) 0.60 0.002 0 .64 0 .0004 -0.27 -0.0002
Current smoker* 0 .50 0.D3 - 0 .25 - 0.003 0 .16 0 .003
Serum potassium 0. 17 0.15 0 .70 0.13 0 .21 0.06
(rnbq/ liter )
Intercept -1.74 - 0 .32 -0.26
*0 = no, I = yes: " Complex" VPB = ;;:: 10 VPB/h or run or multiform complex. Abbreviations as before .
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that may reflect left ventricular impairment [serum lactate
dehydrogenase (LDH) level, cardiothoracic ratio, conges-
tive heart failure, prior myocardial infarction], traditional
risk factors (age, smoking, cholesterol, diabetes mellitus),
and other characteristics (ST depression, complications dur-
ing hospitalization) associated with mortality in this cohort.
In addition, a significant independent contribution of ven-
tricular arrhythmia in predicting mortality was observed when
alternate continuous or categorical descriptors of ventricular
ectopic activity were used (Table 3). Figure I describes the
univariate increasing risk of mortality with increasing num-
ber of ventricular premature beats/h and the goodness of fit
of the 16 variable logistic model . The presence of more
than 0 ventricularpremature beats/h. the presence of pairs
or ventricular tachycardia and the presence of ::::: 10 ventric-
ular premature beats/h and [pair or ventricular tachycardia]
and multiform complexes showed trends that did not reach
nominal statistical significance. The remaining eight defi-
nitions showed statisticallysignificant (adjusted r value ranging
from 2.42 to 4.26) independent associations with total mor-
tality when used alone in the multivariate model. When
atherosclerotic sudden death or atherosclerotic nonsudden
death was considered, the level of significance of the as-
sociations was generally lower. perhaps as a result of the
smaller number of end points.
The relation between ventricularectopic activity and total
mortality, atherosclerotic sudden death and atherosclerotic
nonsudden death persisted when only patients with a Q/QS
Ob>e1ved Death· rate
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Figure l. Rel ation bet ween mortal ity ra te and increasing number
of ventricula r premature beats (VPBs) /h over a mean fo llow-up
period of 2S months . Expected death rate s are based on a 16
variable logistic regression model.
infarction (before the qualifying myocardial infarction), the
age of the patientand the presenceof congestiveheartfailure
during hospitalization for the qualifying infarction. A his-
tory of angina diagnosed by the Rose questionnaire was
associated with two of the three definitions of ventricular
ectopic activity and race with one definition. There was no
relation between ectopic activity and the site (anterior, in-
ferior, Q versus non-Q) of the infarction, serum potassium
or heart rate.
Relation of ventricular ectopic activity to mortality
(Fig. 1, Table 3). In a multivariate logistic regression anal-
ysis, ventricular ectopic activity, defined as the number of
ventricular premature beats/h, was a significant predictor of
total mortality (r = 2.47) independent of other variables
Table 3 . Coeffic ients for Holte r Characteris tics from 33 Mul tivariate * Logist ic Regressions: for Eac h End Point , II Regression s
W ere Run , I for Each Holter Characterist ic
Atherosclerotic Atherosclerotic
Sudden Death (I hour) Nonsudden Death
Total Mortality (16 variable models; ( I I variable models; (12 variable models;
% of deaths = 12911 ,308 = 9.9%) % of deaths = 68/1,528 = 4.5%) % of deaths = 5111,292 = 3.9%)
Holter Characteristic Adjusted Adjusted Logistic Adjusted Adjusted Logistic Adjusted Adjusted Logistic
Used in Model t Value Odds Ratio Coefficient t Value Odds Ratio Coefficient 1 Value Odds Ratio Coefficient
Continuous variables
VPB 2.47 1.003:1: 0 .00296 - 0. 13 0.999 -0.000 14 0.32 1.00 0.00038
LNVPB 2.85 1.23 0.20886 1.62 1.15 0.13933 1.77 1.19 0.1 7663
PAIR 2.63 1.18 0.16 898 - 0.56 0.99 -0.01342 - 0. 15 1.00 -0.00248
VT 4.26t 3.52 1.25838 - 0.47 0.89 -0.11490 2.02t 2.46 0.90090
Categoric variables
VPBO 1.24 1.53 0.42623 1.10 1.71 0.53495 1.49 2.5 1 0.92 121
VPBIO 3.14 2.23 0.80222 1.88 1.81 0.59235 2.24 2.25 0.8 1150
PAIRVT 1.60 1.46 0.37563 1.01 1.34 0. 29596 0.98 1.39 0.32979
OR 3.38 2.07 0.72683 1.90 1.68 0.52026 2.46 2. 13 0.75778
MULT 2.42 1.67 0.5 1184 3.22 2.43 0.88685 0.63 1.2 1 0. 19310
ANDAND 0.69 1.27 0.238 12 0.98 1.47 0.38334 - 0.18 0 .91 - 0 .09837
OROR 3.37 2.02 0. 70458 2.84 2.2 1 0.795 17 1.63 1.65 0.4 9808
*See Appendix for variables controlled in mutivariate analyses . t Walker-Dunean model would not converge. This was calculated from Truett -Cornfield
estimates. :l:This means that there is a 0.3% increase in risk for every increase of one ventricular premature beat/h. ANDAND = VPB 2"IO/h and (VT
event or pair) and multiform complexes (0 = no; I = yes); LNVPB = In (VPB/h + 0.5); MULT = multiform VPB present (0 = no; I = yes); OR
= VPB 2"lOth or VT event or pairs (0 = no; I = yes); OROR = VPB 2"lOth or (VT event or pairs) or multiform complexes; PAIR = VPB pairs/h;
PAIRVT = VT event or VPB pair present (0 = no; I = yes); VPB = ventricular premature beats/h; VPBO = mean VPB/h>O (0 = no; I = yes);
VPBI O = mean VPB/h 2"10 (0 = no; I = yes); VT = ventricular tachycardia events/h. Values in italic denote a t value > 1.96.
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Figure 2. Reciprocal relation between sensitivity and specificity
of seven definitions of ventricular arrhythmias in predicting mor-
tality rate of survivors of acute myocardial infarction. I = VPB
> 0; 2 = VPB ~ 10/h; 3 = VPB pair or VT; 4 = VPB ~ 10/h;
5 = multiform complexes; 6 = VPB ~ IO/h and VPB (pair or
VT) and multiform complexes; 7 = VPB ~ IO/h or VPB pair or
VT or multiform complexes. VPB = ventricular premature beats;
VT = ventricular tachycardia.
wave infarction were considered (odds ratios 2.39 to 2.91,
t = 2.37 to 4.57). In the BHAT placebo group, the mortality
rate in patients with a QIQS wave infarction was not sig-
nificantly different from that in patients with a non-Q wave
infarction (41). A significant association of ventricular ec-
topic activity with nonfatal infarction was not observed.
The usefulness of different definitions of ventricular
arrhythmias (Fig. 2, Tables 4 and 5). Most definitions
of ventricular arrhythmia were multivariately associated with
mortality. Therefore, a different analysis may be useful in
selecting a definition appropriate for a given clinical prob-
lem.
Rates for total mortality, atherosclerotic sudden death
and atherosclerotic nonsudden death cross-tabulated by the
presence or absence of the seven categorical definitions of
ventricular ectopic activity are presented in Table 4. Again,
in this univariate analysis, all definitions showed a signif-
icant association with all three mortality classifications. The
odds ratios were also similar (2.18 to 2.69). However, the
sensitivity (percent of patients who died and also had ectopic
activity by a given definition at baseline study) and speci-
ficity (percent of patients who did not die and did not have
arrhythmia by that definition) of the different definitions in
predicting future mortality were markedly different (Table
5). These are presented pictorially as a "receiving operator
characteristic curve" in Figure 2 (42). Definitions with high
Table 4. Event Rates by Holter Variable
Total Mortality Atherosclerotic Sudden Death Atherosclerotic Nonsudden
«I hour) Death
Total No. Death Odds Z of Death Odds Z of Death Odds Z of
of Patients Rate (%) Ratio Diff. Rate (%) Ratio Diff. Rate (%) Ratio Diff.
Overall 1,640 9.9 4.6 4.0
VPB >0/24 h
Yes 1,380 10.9 5.1 4.5
No 260 5.0 2.32 2.90 2.3 2.26 1.95 1.5 3.01 2.22
VPB ~lO/h
Yes 21l 19.9 9.0 s.t
No 1,429 8.5 2.69 5.18 4.0 2.38 3.24 3.4 2.47 3.19
VPB pairor VT present
Yes 327 16.5 2.18 4.44 8.0 2.18 3.19 6.7 2.08 2.78No 1,313 8.3 3.8 3.4
VPB ~ IOlh or (VPB
pairor VT)
Yes 418 17.2 2.59 5.77 7.9 2.35 3.67 7.2 2.55 3.80No 1,222 7.4 3.5 2.9
Multiform present
Yes 538 15.2 2.27 5.02 8.7 3.54 5.52 5.6No 1,102 7.4 2.6 3.3 1.75 2.23
VPB ~ IOlh and (pairor
VT) and multiform
complexes
Yes 112 19.6 2.40 356 10.7 2.75 3.17 7.1No 1,528 9.2 4.2 3.8 1.95 1.74
VPB ~ 10lh or (pairor
VT) or multiform
complexes
Yes 666 15.2 2.63 5.85 7.7 3.15 4.82 5.9No 974 6.4 2.6 2.8 2.18 3.12
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Table 5. Sensitivity and Specificity of Seven Categorical Definitions of Ventricular Arrhythmia in Predicting Mortality
No. of No. With No. Without
Deaths Arrhythmia Sensitivity No. Alive Arrhythmia Specificity
Arrhythmia Definition (a) (b) (c = b/a) (d) (e) (f = e/d)
Total Mortality
VPB > 0/24 h 163 ISO 0.920 1,477 247 0. 167
VPB 2: IO/h 163 42 0.258 1,477 1,308 0.886
VPB pair or VT 163 54 0.33 1 1,477 1,204 0.8 15
present
VPB 2: IO/h or VPB 163 72 0.442 1,477 1, 131 0.766
pair or VT
Multiform present 163 82 0.503 1,477 1,021 0.69 1
VPB 2: 10/h and pair or 163 22 0. 135 1,477 1,387 0.939
VT and multiform
VPB 2: 10/h or pair or 163 101 0.620 1,477 912 0.617
VT or multiform
Atherosclerotic Sudden Death « I hour)
VPB > 0/24 h 76 70 0.92 1 1,564 254 0.162
VPB 2: IO/h 76 19 0.250 1,564 1,372 0.877
VPB pair or VT 76 26 0.342 1,564 1,263 0.808
present
VPB 2: IO/h or VPB 76 33 0.43 4 1,564 1,179 0.754
pair or VT
Multiform present 76 47 0.6 18 1,564 1,073 0.686
VPB 2: 10/h and pair or 76 12 0.158 1,564 1,464 0.936
VT and multiform
VPB 2: IO/h or pair or 76 51 0.67 1 1.564 949 0.607
VT or multiform
Nonsudden Atherosclerotic Death
VPB > 0/24 h 66 62 0.939 1,574 256 0. 163
VPB 2: IO/h 66 17 0.258 1,574 1,380 0.877
VPB pair or VT 66 22 0.333 1,574 1.269 0.806
present
VPB 2: 10/h or VPB 66 30 0.4 55 1,574 1,186 0.753
pair or VT
Multiform present 66 30 0.4 55 1.574 1,066 0.677
VPB 2: IO/h and pair or 66 8 0. 121 1,574 1,470 0.934
VT and multiform
VPB 2: 10/h or pair or 66 39 0.59 1 1,574 947 0.602
VT or multiform
Abbreviations as in Table 3.
sensitivity and low specificity (for example , ventricular pre-
mature beats > O/h) or vice versa (for example, ventricular
premature beats ::::: 10/h and pairs or ventricular tachycardia
and multiform complexes) may be identified. The inverse
relation of sensitivity and specificity is evident. Using two
additional categoric ventricular ectopic activity definitions
(presence of ventricular tachycardia; presence of ::::: 10 ven-
tricular premature beats/h and [pairs or ventricular
tachycardia)) gave similar results. For ventricular tachy-
cardia, sensitivity was 0.17 and specificity was 0.93 ; for
the presence of both greater than 10 ventricular premature
beats/h and pairs or ventricular tachycardia, sensitivity was
0.147 and specificity was 0.935 .
Prediction of mortality in patient subsets defined by
clinical variables (Fig. 3, Table 6). Good stratification of
risk was obtained with the use of three clinical characteristics
[history of prior myocardial infarction, cardiomegaly (that
is. cardiothoracic ratio > 0 .5) and ST depre ssion on the rest
electrocardiogram) . Four subsets of patients with mortality
rates ranging from 4.7 to 35.5% were defined by the pres-
ence of none , one , two or three characteristics . The presence
of ventricular ectopic activity increased the risk in all sub-
sets . The risk ratios for patients with and without arrhythmia
and the level of significance of the differences in mortalit y
were higher in the low risk and numerically larger strata .
For the purposes of this analysis, ectopic activity was de-
lACC Vol. 10, No.2
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NUMBER OF RISK FACTORS PRESENT
fined as the presence of 2': 10 ventricular premature beats/h
or pairs or ventricular tachycardia or multiform complexes.
Figure 3. Total 25 month mortality and sudden death mortality
according to the number of .'risk factors" [prior myocardial in-
farction, cardiothoracic ratio >0.5, ST depressionon rest electro-
cardiogram and the presence or absence of ventricular ectopic
activity (~1O ventricular premature beats/h or pairs or ventricular
tachycardia or multiform complexes)].
Discussion
Ventricular ectopic activity in survivors of acute myo-
cardial infarction. The prevalence of the different forms
of ventricular ectopic activity observed in this study was
similar to that previously reported by some investigators
(11,26), but lower than that reported by others
(10,16,18,19,30,33). Discrepancies in the prevalence of ec-
topic activity among different studies may be due to different
characteristics of the study groups under consideration. dif-
ferent recording methodology. exclusion criteria, the use of
antiarrhythmic agents during ambulatory ECG and other
factors. In this study, antiarrhythmic agents were used by
291 patients ( 17.7%) and certain types of high risk patients,
including those with uncontrolled congestive heart failure,
were excluded. The association of left ventricular dysfunc-
tion with ventricular arrhythmias and mortality may explain
why both ectopic activity and mortality were higher in other
series of survivors of acute myocardial infarction
(18,19.32-34).
This study confirms previous findings (1/ ,33,43--45) of
a strong relation between ventricular ectopic activity and
left ventricular dysfunction. Thus, the presence of conges-
tive heart failure and history of myocardial infarction before
the qualifying infarction, two factors related to left ventric-
ular dysfunction, were associated with ectopic activity in
this study. An independent effect of age on ectopic activity
was also observed in this cohort, and has been previously
reported (46-48) in patients with and without cardiac dis-
ease. A relation to the site of infarction (transmural versus
subendocardial, anterior versus inferior) was not seen (43).
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Relation of ventricular ectopic activity to mortality of
survivors of acute myocardial infarction. This relation
has been the subject of many reports. Although some smaller
studies (34,43,49,50) did not show such a relation, the
majority of reports (15, 16,19,24,25,29,30,32,33) show that
patients with ectopic activity, especially frequent or com-
plex, have higher mortality rates. There is still some ques-
tion as to whether the relation between increased mortality
and ectopic activity is independent of other factors influ-
encing prognosis, such as left ventricular dysfunction.
Because left ventricular dysfun ction is both a major pre-
dictor of mortality and an important determinant of ven-
tricular ectopic activity, it has been postulated that arrhyth-
mias do not independently contribute to the risk, but are
merely markers of severe disease (myocardial damage). ln
this study, multiple logistic regression identified ectopic
activity as an independent predictor of mortality after nu-
merous other variables, including factors indirectly reflect-
ing or associated with left ventricular dysfunction (prior
myocardial infarction, cardiothoracic ratio. history of
congestive heart failure, elevated LDH or use of digitalis),
were taken into consideration (Fig. I).
Contrary to a recent report (35) of 586 patients, we found
that ventricular ectopic activity was a significant predictor
of risk in patients with a Q/QS wave infarction. This dif-
ference may be a result of patient selection, other metho-
dologic differences (for example, ambulatory ECG was not
a required part of the protocol, different definitions of sig-
nificant Q waves) or chance.
Risk stratification based on clinical variables and ven-
tricular ectopic activity. Cardiac catheterization, estima-
tion of ejection fractionusing radionuclides, exercise testing
and invasive electrophysiologic studies have been used for
risk stratifi cation of survivorsof acute myocardial infarction
(51- 59). These expensive techniques have significant eco-
nomic impact when applied to all patients with a common
disorder such as myocardial infarction. The present study
shows that stratifi cation of patients according to risk of
future mortality may be done using easily obtainable and
inexpensive clinical criteria such as the history of a prior
myocardial infarction, ST depression on the rest ECG and
cardiomegaly on chest X-ray film. These factors, which
were also associated with increased mortality in previous
studies (12,21,45,49,60- 63), resulted in a 7.5-fold risk dif-
ferential with the 25 month mortality rate varying from 4.7%
with none of the three factors present to 35.5% when all
three factors were present (Fig. 3, Table 6). This is either
similar or better than the stratification reported by other
workers (51- 59) using radionuclide imaging, exercise test-
ing or electrophysiologic study.
Ambulatory ECG is frequently employed in patients re-
covering from acute myocardial infarction to estimate the
risk of future mortality. Because the risk is high mainly in
patients who have both left ventricular dysfunctionand fre-
quent or complex ventricular ectopic activity, physicians
tend to employ ambulatory ECG only in patients who have
significant left ventricular dysfunction, multiple infarctions
or other factors associated with high risk. In this study,
ventricular ectopic activity increased the risk in all risk
strata, allowing identification of eight subsets with a 17-
fold risk range. For sudden cardiac death, the mortality rate
varied from 0,8 to 29.4%. This risk ratio of 38 (highest to
lowest stratum) is almost 3.5 times higher than that found
by Mukharji et al. (33), who classified Multicenter Inves-
tigation of the Limitation of Infarct Size (MILlS) patients
by ejection fraction and ventricular ectopic activity. In the
present study of the BHAT placebo group, although the
absolute increment of risk imposed by ectopic activity was
similar in the four mortality strata defined by the history of
prior myocardial infarction, ST depression and cardiomeg-
aly. the risk ratio was higher in the low mortality subset
that included the largest number of subjects. In this subset
(patients without ST depression. cardiomegaly or prior in-
farction), ectopic activity almost quadrupled the risk. This
suggests that if ambulatory ECG is used for risk stratifi-
cation, its use should not be confi ned only to high risk
patients.
Association of ventricular ectopic activity with both
sudden and nonsudden coronary death. A probable
mechanism by whichectopicactivity may be associated with
increased mortality independently of other factors is pre-
cipitation of ventricular fibrillation (for example, R on T
ventricular premature beats may precipitate ventricular
tachycardia and fibrillation). Nonsustained asymptomatic
ectopic activity may also be a marker of " electrical insta-
bility" or tendencyof the ventricles to fibrillate. From these
considerations, one would expect the mortality risk ratios
to be higher for sudden death than for nonsudden coronary
death. This pattern was not consistently observed in this
study. In other studies (24), ventricular arrhythmias, es-
pecially repetitiveforms, were found to be the best predictor
for sudden cardiac death, whereas congestive heart failure
was a stronger predictor of nonsudden death. Variability in
the defini tion of sudden cardiac death as to the time interval
from the onset of symptoms (for example, instantaneous or
I hour) or as to circumstances (for example, exclusion of
patients who had clinical or pathologic evidence of acute
myocardial infarction even if they died within I hour of the
onset of symptoms) may be responsible for the different
results. in addition to the differences between studies men-
tioned earlier (19,33). The lack of preferential association
of ectopic activity with sudden rather than nonsudden death
may imply that asymptomatic ectopic activity is a marker
of electrical instability that increases the risk of death in all
patients with coronary artery disease (both in the presence
and absence of clinically recognized ischemic events such
as myocardial infarction).
Value of different definitions of ventricular ectopic
activity in risk stratification. Much discussion has been
devoted to whether frequency or complexity of ectopic ac-
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tivity is the stronger predictor of mortality in survivors of
acute myocardial infarction.The data fromBHAT combined
with those frompreviousreports indicate thatboth frequency
and complexity are important. In BHAT, low frequency of
ventricular premature beats « IO/h) or absence of repetitive
ventricular premature beats was associated with lower (8.5
and 8.3%, respectively) mortality thaneither high frequency
( ~ I O/h ) of ventricular premature beats (mortality 19.9%)
or presence of complex forms (pairs or ventricular tachy-
cardia, 16.5% mortality). Amongthe differenttypes of com-
plexity, the risk ratios for the presence of repetitive forms
and multiform ventricular premature beats were similar. In
some previous studies (19,24,25), repetitive forms were
found to increase risk to a higher degree than the presence
of other types of complexity, while in other studies (33), a
ventricularpremature beat frequency ~ 10th was a stronger
predictor.
Because the great majority of survivors of acute myo-
cardial infarction manifest some ventricularectopic activity
on 24 hour ambulatory ECG, the mere presence of ventric-
ular premature beats is not useful in identifying high risk
subgroups. More malignant forms (for example. ~ 10 ven-
tricular premature beats/h, multiform complexes and pairs
or ventricular tachycardia) identify subgroups at high risk.
Appendix
but occur in only a small percent (6.7%) of patients and in
only a small percent (13.5%) of patients who will die.
Selection of an appropriate arrhythmia definition.
Physicians facing the decision of whetheror not to intervene
(for example. treat with antiarrhythmic agents) prefer to use
categoricdefinitions of ventricularectopic activity. All such
definitions applied in BHAT were associatedwith increased
mortality with similar odds ratios (ranging from 2.18 to
2.63). Therefore, in this respect, the definitions of ectopic
activity are similar (that is, univariably, the odds of dying
for a patient withone or more ventricularprematurebeats/24
h were 2.32 times higher than the odds for a patient without
any ventricular premature beats/24 h; or the odds of dying
for a patient with paired beats or ventricular tachycardia
were 2.18 times higher than the odds for a patient without
pairs or ventricular tachycardia) (Table 4). On multivariate
analysis. the odds of dying for a patient with one or more
ventricular premature beats124 h were 1.53 times higher than
the odds for a patient without any ventricular premature
beats/24 h. and the odds of dying for a patient with pairs
or ventricular tachycardia were 2.07 times higher than the
odds for a patient without pairs or ventricular tachycardia
(Table 3).
A more useful approach in deciding on the appropriate
Patient Characteristics at Entry Used as Independent Variables in the Multiple Logistic
Regression Models
Patient Characteristics
Age (yr)"
Employed '
Current cigarette smoker '
Prior myocardial infarction '
Diastolic blood pressure (mm Hg)
Systolic blood pressure (mm Hg)
Heart rate (beats/min)
Hematocrit (%)
Serum cholesterol (mg/dl)
Elevated LDH*
Anteriorly located infarction (from ECG)*
ST depre ssion (from ECG) *
Major left ventricular hypertrophy (from ECG )*
Cardioth oracic ratio (from X-ray film)
Experienced complications durin g hospitalizat ion"
History of congestive heart failure*
History of diabetes*
Beta-blocker use before BHAT myocardial
infarction '
Ant iplatelet use at entry
Digitalis use at entry*
Antiarrhythmic drug use at entry*
(Holter characteristic from 24 hour Holter) '
Total
Mortality
x
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Atherosclerotic
Sudden Death
X
X
X
X
X
X
X
X
X
X
X
Atherosclerotic
Nonsudden
Death
x
X
X
X
X
X
X
X
X
X
X
X
o = No. I = Yes. ECG = electrocardiogram: LDH = lactic dehydrogenase .
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definition of ventricular ectopic activity for a given clinical
or research setting is to use information included in Tables
4 and 5. When only a subset of patients with high or low
mortality is to be identified, the data presented in Table 4
are useful. For example, a person with 2: 10 ventricular
premature beats/hour and multiform complexes and pairs or
ventricular tachycardia has a mortality rate approximately
four times higher (19.6% in 25 months) than a person with-
out any ventricular premature beats in 24 hours (5.0%).
Treatment of only the patients with this definition of ven-
tricular arrhythmia would afford a potential benefit only to
13.4% (22 of 163) of the patients who eventually die and
would not benefit the majority of patients at risk. Therefore,
it is important to consider not only the risk of a given subset
of patients with a given definition of ectopic activity, but
also the sensitivity of each categoric definition of arrhythmia
in identifying patients who died and the specificity of the
definition in identifying patients who did not die during
follow-up (Fig. 2, Table 5). By using this type of analysis,
it becomes easier to tailor the definition of ectopic activity
to the proposed intervention.
When an intervention with a low level of adverse effects
is contemplated, a definition with a high sensitivity (and
low specificity) can be employed to offer the benefit to most
patients at risk of dying. The large number of patients not
at risk who will be treated because of the low specificity of
the definition will not suffer severe adverse reactions. On
the other hand, when interventions that are expensive or
carry significant risk or suffering are considered, a definition
with a high specificity can be chosen to avoid treating a
large number of persons not at increased risk of dying with
a potentially toxic agent. In this case, however, the percent
of persons that will be treated will be low.
Although ventricular ectopic activity is associated with
an increased mortality in survivors of acute myocardial in-
farction and although it most probably contributes to the
risk independently of other factors, there is no evidence to
date that treatment of the arrhythmia reduces the risk. Pub-
lished studies (64) of antiarrhythmic therapy in acute myo-
cardial infarction have not proved a beneficial effect. How-
ever, these studies were small (low statistical power), the
particular antiarrhythmic agents tested may not have been
effective, single drugs in fixed doses were used and, in some
studies, ambulatory EeG to define the risk and the efficacy
of treatment was not employed. A pilot study on this issue
has been completed and a large study is now in progress
(65).
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